← Back to Search

Acupressure for Withdrawal Syndrome

N/A

Waitlist Available

Led By Heather Jackson, MSN, APRN

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial will assess whether auricular acupressure is an effective non-pharmacologic therapy for infants at risk for IWS in the PCICU.

Eligible Conditions

Iatrogenic Withdrawal Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention pilot feasibility study will assess the impact of auricular acupressure

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Acupressure stickers will be applied to one ear in accordance with the NADA protocol acupuncture technique.

Group II: No InterventionActive Control1 Intervention

No intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

856 Previous Clinical Trials

672,152 Total Patients Enrolled

Heather Jackson, MSN, APRNPrincipal InvestigatorVanderbilt University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies remaining for this experimental treatment?

"Affirmative. Evidence found on clinicaltrials.gov reveals that this experiment - which was initially listed on October 25th 2021 - is actively enrolling patients. In total, 40 participants need to be sourced from 1 medical centre."

Answered by AI

How many test subjects are taking part in this research endeavor?

"Affirmative. Per the information provided on clinicaltrials.gov, this investigation is still enrolling participants. It was first posted in October of 2021 and its newest update occurred June 5th 2022; 40 individuals from one site are needed for participation."

Answered by AI

Recent research and studies

Pediatric Critical Care MedicineJournal

Implementation of a Risk-stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU

Amirnovin, Rambod, L. Nelson Sanchez-Pinto, Carol Okuhara, Phuong Lieu, Joyce Y. Koh, John W. Rodgers, and Lara P. Nelson. 2018. “Implementation of a Risk-stratified Opioid and Benzodiazepine Weaning Protocol in a Pediatric Cardiac ICU”. Pediatric Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/pcc.0000000000001719.

Seminars in Fetal and Neonatal MedicineJournal

Perinatal and Neonatal Use of Sedation and Analgesia

McPherson, Christopher, and Terrie Inder. 2017. “Perinatal and Neonatal Use of Sedation and Analgesia”. Seminars in Fetal and Neonatal Medicine. Elsevier BV. doi:10.1016/j.siny.2017.07.007.

European Journal of Pediatric SurgeryJournal

Safeguarding Infant Brains: A Multidisciplinary Challenge—results of a Survey, Update on Current Scientific Evidence, and Recommendations on How to Deal with Possible Anesthetic Drug Neurotoxicity

Vlot, John, Rene Wijnen, and Frank Weber. 2017. “Safeguarding Infant Brains: A Multidisciplinary Challenge—results of a Survey, Update on Current Scientific Evidence, and Recommendations on How to Deal with Possible Anesthetic Drug Neurotoxicity”. European Journal of Pediatric Surgery. Georg Thieme Verlag KG. doi:10.1055/s-0037-1603641.

Pediatric AnesthesiaJournal